Objective. Examine traditional and uncompensated health care utilization associated with chronic noncancer pain.
Introduction
How to treat chronic noncancer pain (CNCP) has become a major issue for primary care providers. Treatment of CNCP with opioids remains prevalent despite a lack of evidence supporting their use beyond the short term, as well as growing concerns with opioid-related aberrant behaviors and adverse events, such as constipation, somnolence, or overdose [1] . While opioid use and misuse remains an important topic, health care utilization related to CNCP is equally relevant.
Chronic pain is associated with a number of comorbidities, most notably mental illness but also diabetes, hypertension, and tobacco use [2, 3] . It should then come as no surprise that past studies have noted an association between various types of chronic pain and increased health care utilization [2, [4] [5] [6] [7] [8] . However, most previous studies generally focused on a single type of pain and many were conducted outside the United States [7, [9] [10] . Health care utilization is commonly viewed as emergency room (ER) and clinic visits, hospitalizations, specialty services, procedures, and drug prescriptions. The costs of these resources can be calculated, and concrete figures provided, when describing the rising costs of health care. What is more difficult to ascertain is the monetary value associated with tasks not necessarily billed.
Primary care providers (PCPs) shoulder most of the burden related to CNCP management, a result of being the primary "point of service" into health care [11] . In addition, PCPs' responsibilities extend beyond the clinic visit and include answering questions, dispensing advice to patients through telephone calls and secure messages, and fielding after hour calls. These aspects can be time consuming, frequent in nature, and are usually not compensated.
The patient-centered medical home (PCMH) offers a team-based approach in managing patients with chronic diseases [12] , such as chronic pain. The model has been shown to improve health care outcomes, costs, and provider satisfaction [13] [14] [15] , making it valuable and potentially necessary in the management of chronic pain.
While increased health care utilization is seen with chronic pain, it is unknown whether this also holds true for patients on higher opioid doses or stronger opioids. It is also unclear whether there is an association between patients on pain agreements and utilization, which might provide a different angle in supporting agreement use beyond current recommendations.
The objectives of this study are to summarize health care utilization produced by patients stratified by the four prespecified variables: 1) presence of chronic pain; 2) pain agreement status; 3) opioid dose; and 4) opioid schedule. We also examine whether these variables are predictive of health care utilization.
Methods

Study Design and Setting
This was a retrospective chart review of internal medicine clinic patients at a tertiary academic medical center in Milwaukee, Wisconsin. Medical records were extracted from EPIC, the electronic medical record (EMR) utilized by the clinic's health system. This study was approved by the Medical College of Wisconsin (MCW) Institutional Review Board.
Study Sample
Potential subjects with chronic pain were identified through the i2b2 Clinical & Translational Research Informatics Data Warehouse at MCW. Subjects were at least 18 years old and either on a pain agreement or were prescribed at least three months of opioids between April 1, 2014, and April 1, 2015. Long-term opioid use was defined as having three or more monthly prescriptions, based on prior studies and the generally accepted definition of chronic pain as lasting for more than 12 weeks [16, 17] . Prescriptions did not need to be consecutive.
Patients with active cancer, on hospice, prescribed an opioid within six months of surgery, or not seen in clinic at least once in the established time frame were excluded. The study's main subjects with chronic pain were matched to clinic patients not on a pain agreement or long-term opioids by age and gender and served as controls.
Data Collection
Patient demographics (age, gender, race), diagnoses, pain agreement status, provider characteristic (resident or faculty), health care utilization (emergency room visits, hospitalizations, clinic visits, after hour calls, telephone/ secure messages), and current opioid regimen for pain patients were obtained. Telephone and secure messages were fielded by PCPs or nurses. Current opioid regimen was the patient's medication(s) at the end of the study period. Data were entered and stored in Research Electronic Data Capture (REDCap), which is a secure, web-based application designed to support data capture for research studies [18] .
Clinic and State Policy
The clinic uses a standardized pain agreement. It includes a plan of care, pain description, prior and current opioid regimen, and terms and conditions of the agreement. This includes possible discontinuation of opioids or dismissal from clinic if the agreement is violated. Patients on long-term opioids are not required to have any specific clinic contact (nurse visits, telephone calls). Timing of urine drug screen (UDS) and assessment intervals are up to individual providers. Patients on pain agreements are placed on a monthly refill schedule that does not require them to call for refills. The refills are automatically sent directly to the patients' pharmacies. At the state level, Wisconsin does not require a minimum number of clinic visits for patients on long-term opioids, and there is no law regarding prescription drug monitoring program (PDMP) checks. Wisconsin's PDMP was already operational at the time of the study.
Measures
The examined measures of health care utilization included counts of emergency room (ER) visits, hospitalizations, primary care and urgent care visits, after hour calls, telephone calls, and secure messages. Telephone calls and secure messages were excluded if they were related to nonopioid prescription refills, hospital discharge follow-up, or home care agency plan of care. These specific encounters are clearly labeled as such in the EMR and are easily identifiable. Most prescriptions refill requests were related to nonopioid medications for nonpain conditions, such as diabetes and hypertension. They were excluded to avoid overestimating calls and messages. Hospital discharge follow-up was not included as these telephone calls are done per protocol. Home care agency plan of cares were also excluded as these are typically quarterly forms that usually only need a provider's signature without any additional tasks. The study clinic is a patient-centered medical home; however, the management of patients with chronic pain is exclusively left to providers. Accordingly, pharmacy visits were not included as the clinic pharmacists are not involved with chronic pain management, and the clinic does not offer nurse visits for chronic pain.
Instances of each utilization variable were counted manually. Telephone calls and secure messages were combined into a single measure. The morphine equivalent dose was calculated for each patient on long-term opioids. The Oregon Health & Science University calculator was used to convert each patient's opioid regimen to a daily morphine milligram equivalent [19] . The calculator's conversion factors have been used in previous studies [20, 21] .
Analysis
Demographic and clinical characteristics were compared among pain and pain agreement groups using chi-square and t tests for categorical and continuous variables, respectively. Descriptive statistics and univariate analyses (chi-square or Fisher's exact tests, where appropriate) were used to compare instances of health care utilization as counts by chronic pain status in the overall cohort and by pain agreement status and opioid dose, schedule, and number of prescriptions in the pain cohort. Logistic regression was used to jointly assess predictors of each health care utilization outcome, with ER visits, hospitalizations, and after hour calls (any vs none) as binary outcomes and office visits (1, 2-3, 4-5, 6þ) and phone/e-mail contacts (0-3, 4-6, 7-12, 13þ) as ordinal outcomes. Adjacent categories of the ordinal outcomes were pooled where cell sizes were small or the mean of the chronic pain indicator was similar across categories. For each model outcome, stepwise variable selection was used on 50 bootstrap sample replicates of the complete data to generate a stable, parsimonious list of predictors from the following characteristics: age; gender; race; resident or attending physician; diabetes, obesity, and hypertension; tobacco use or substance abuse; cardiac, renal, and pulmonary disease; arthritis; neuropathy; and acetaminophen or antiepileptic prescriptions. The automated selection process retained variables in each bootstrap sample using a significance cutoff of 0.2, and included in the final model only those variables that were retained in at least 20 (40%) of bootstrap samples. From these models, odds ratios and corresponding predicted probabilities for each outcome were calculated to examine the effect of chronic pain status on utilization, controlling for relevant demographic characteristics and comorbid conditions more prevalent among chronic pain patients [22] .
Results
A total of 2,094 patients (23%) of the clinic population were identified as meeting criteria for long-term opioid use. Of these, 834 met criteria for study inclusion. Among patients with CNCP, 335 (40.2%) were on a pain agreement with the clinic. In both the pain and nonpain groups, the mean age was 61 years (SD ¼ 13 years) and approximately one-third of patients were male. Overall characteristics of patients with chronic noncancer pain are seen in Table 1 .
Patients with CNCP were likely to have more ER and clinic visits, hospitalizations, after hour calls, and telephone and secure messages compared with patients without chronic pain (all P < 0.001) ( Table 2) .
Pain Agreement Status
When examined by pain agreement status, there were no differences in the number of ER and clinic visits and after hour calls between patients with and without a pain agreement. The pain agreement group, however, did have more telephone calls and secure messages than the group without a pain agreement (P ¼ 0.002), as well as fewer hospitalizations (P ¼ 0.04) ( Table 2) .
Morphine Equivalent Dose
All opioids were included in the determination of each patient's total daily morphine equivalent dose (MED) as long as they were on the patient's medication list as of April 1, 2015. Three MED groups were formed based on previous studies: less than 100 mg, 100-200 mg, and more than 200 mg [23, 24] .
Most patients had a total daily morphine equivalent dose of less than 100 mg (N ¼ 634, 82.6%). There were 67 patients (8.7%) on 100-200 mg and 67 patients (8.7%) on more than 200 mg a day. Patients on 100 mg or more a day were more likely to have a single clinic visit compared with patients on less than 100 mg, who were more likely to have two or more visits in a year (P ¼ 0.025) ( Table 3) . Table 2 Health care utilization by chronic pain and pain contract status 
Controlled Medication Schedule
Schedule III and IV controlled medications were combined into a single category given the relatively small numbers of each individually. Irrespective of pain agreement status, patients on schedule II medications were more likely to have a higher number of clinic visits in a year (P ¼ 0.004) compared with patients on schedule III or IV medications. Patients on schedule II medications also had more after hour calls (P ¼ 0.003), hospitalizations (P ¼ 0.006), and telephone or secure messages (P ¼ 0.001). There were no significant differences in ER visits (Table 4) .
Number of Opioids
The majority of patients with chronic pain were prescribed a single opioid (N ¼ 608, 79%). Patients prescribed more than one opioid were more likely to have only one clinic visit in the year (P ¼ 0.03). There were no differences in total ER visits, hospitalizations, after hour calls, and telephone and secure messages (Table 4) .
Logistic Regression
Model-based results show that the odds of a chronic pain patient having one or more ER visits were 2.6 (95% CI ¼ 2.0-3.4) times the odds of a nonpain control patient, controlling for relevant demographic characteristics and comorbid conditions associated with CNCP.
Similarly, the odds of a chronic pain patient being hospitalized one or more times were 5 (95% CI ¼ 3.7-7.0) times the odds of a nonpain patient.
Patients with CNCP were more likely to have a greater number of clinic visits (adjusted common odds ratio ¼ 3.4, 95% CI ¼ 2.7-4.2) and were 2.3 (95% CI ¼ 1.7-3.0) times more likely to have an after hour call compared with patients without CNCP. Likewise, patients with CNCP were more likely to have a higher number of telephone and secure messages than patients without chronic pain (adjusted common odds ratio ¼ 2.9, 95% CI ¼ 2.3-3.6) ( Table 5 ). For each model, adjusted predicted probabilities were calculated for all possible outcomes and averaged by chronic pain category ( Figure  1 ).
Discussion
Chronic pain, in and of itself, has been shown to be associated with higher health care utilization [25] [26] [27] [28] [29] . Past studies, however, focused mainly on traditional health care resources, such as ER, primary and specialty care visits, and hospitalizations. Our results show that patients with chronic pain were significantly more likely to utilize both traditional and nonbillable health care resources, compared with patients without chronic pain, controlling for relevant clinical factors.
Our study population was similar to those of previous works. In line with those studies, our overall clinic population and chronic pain population were predominately female. Past studies have demonstrated that females tend to utilize ambulatory services more often than men and are more often afflicted by chronic pain [30] [31] [32] [33] .
There is a number of possibilities as to why patients with chronic pain use more resources. Inadequate pain control may be an obvious explanation. Complications associated with chronic opioid use like opioid dependence and opioid use disorder may also play a role.
Patients with opioid addiction, for example, might contact their PCPs or present to the ER if they've run out of medications or in an attempt to obtain more. It may also be that providers require more clinic visits or have more contact through telephone calls and secure messages for close monitoring.
The increase in ER visits and hospitalizations may reflect the inability to adequately monitor some patients. This would hint at the workload involved with guidelinerecommended opioid monitoring practices. These CI ¼ confidence interval; OR ¼ odds ratio. *Models were adjusted by applying a stepwise model selection process to the following patient characteristics: age; gender; race; resident or attending physician; diabetes, obesity, and hypertension; tobacco use or substance use disorder; cardiac, renal, and pulmonary disease; arthritis; neuropathy; and acetaminophen or antiepileptic prescriptions. † Adjusted odds ratio given any vs none as binary outcome. ‡ Adjusted common odds ratio for the ordinal outcome of 1, 2-3, 4-5, or 6þ visits. § Adjusted common odds ratio for the ordinal outcome of 0-3, 4-6, 7-12, or 13þ telephone or secure message contacts.
processes are not inconsequential in terms of time and resources.
Our study found that there were some utilization differences based on pain agreement status. Patients on agreements had more telephone and secure messages but fewer hospitalizations. The latter might be expected if agreements were used for patients with well-controlled pain or if monitoring were satisfactory. Telephone and secure messages may be higher for patients on agreements due to close monitoring or ongoing pain issues. Further work is needed to understand the reasons for these findings.
There were significant differences in health care utilization by number of prescribed opioids, morphine equivalent dose, and controlled medication class. Schedule III and IV medications are felt to have less risk compared with those of schedule II, which is ultimately how the controlled medication classification was created [34] . Less health care utilization for lower schedule opioids may reflect this lower potential for abuse and misuse. For example, providers may be more comfortable prescribing lower-risk opioids without regular follow-up.
Interestingly, patients on two or more opioids and those on higher MEDs were more likely to have a single clinic visit in a year. It is possible that those prescribed multiple or stronger opioids are on pain agreements, which can make monthly attainment of opioids relatively simple and circumvent routine clinic visits. This should cause providers to question whether the subsequent decrease in patient contact is something to be desired and reflect on how and why they use pain agreements. It seems intuitive that a safer practice model should lead to more surveillance of patients on high MED or multiple opioids as risk for adverse events increases with higher doses [35] . Less frequent oversight may contribute to greater Figure 1 Average adjusted predicted probabilities of health care utilization by chronic pain status.
societal harm by potentially missing opportunities to prevent misuse and allowing an unregulated, steady stream of high-dose opioids.
To our knowledge, this is the first study to examine uncompensated health care utilization associated with managing patients with chronic pain. Nonbillable provider tasks and responsibilities are rarely mentioned but are an integral part of primary care. Inability to estimate their costs unfortunately undermines their importance as these tasks can involve considerable time and effort on top of already demanding clinic schedules. In fact, past studies have shown that PCPs spend a significant amount of time outside the clinic visit engaged in patient care activities [36] [37] [38] . For one five-physician practice, this meant on top of an average of 18 patient visits a day, each physician also had an average of 24 phone calls and 17 secure messages a day [36] .
While this aspect of being a primary provider is essentially unseen by those outside of medicine, it is evident to those on the other side, including medical trainees [39, 40] . Unsurprisingly, internal medicine residents and medical students continue to shy away from primary care [41] [42] [43] , adding another obstacle for those trying to find solutions to the primary care shortage [44] .
In terms of current primary care providers, the work beyond the actual clinic visit, which includes telephone calls and paperwork, has been shown to be stressful and related to burnout [45] . This is concerning not only for provider well-being but also for patient access and the quality of patient care provided. Therefore, attempts to quantify and study this type of health care utilization are critical to promote PCP career satisfaction, workforce expansion, and innovative models of care.
The chronic care model (CCM) is a framework proven to improve the management of chronic conditions such as diabetes and COPD [46, 47] . The model has six main elements: community resources and policies, health care organization, self-management support, delivery system design, decision support, and clinical information systems [48] . Each element, once developed, incorporated, and implemented into a clinic allows for standardized care. This scheme may be particularly important in regards to safe opioid prescribing.
The PCMH model can be viewed as a way to implement the chronic care framework and may also be crucial in the management of patients with chronic pain [49, 50] . As with the CCM, tasks associated with safe opioid prescribing, such as regular follow-up and review of the PDMP, could be standardized and redistributed to other health care team members. This could decrease some of the monitoring responsibility providers face, as well as improve overall workload and burnout. The reality, however, is that not all clinics are PCMHs, nor do many have the infrastructure, finances, or manpower to provide team-based care. This consequently keeps many PCPs in an isolated role monitoring and managing chronic pain.
As states attempt to curb the opioid epidemic through new laws and regulations, a team-based and standardized approach seems necessary to provide safe, effective, and guideline-concordant management of chronic pain. Even before the Centers for Disease Controls and Prevention (CDC) Guideline for Prescribing Opioids for Chronic Pain was published, some states already had laws in place requiring that providers or their delegates access the PDMP before prescribing opioids [51] . Other CDC recommendations, such as the frequency of evaluating the benefits and harms of opioid therapy, could become mandatory. Standardization of pain management and new laws may make opioid prescribing safer but would also likely impact health care utilization. Their effect could be bidirectional with a decrease in ER visits and hospitalizations and an increase in clinic visits and telephone contacts.
Limitations
There are limitations to the study. First, subjects are from an academic medical center, which is known to draw patients with challenging and often complex medical conditions. It is debatable whether the patient population can be generalized to community clinics or even other medical centers. Second, given the scope of our study, it was not possible to differentiate the reasons for each health care utilization measure or limit them to just those related to pain. Likewise, we did not separate clinic visits into regular follow-up and urgent care appointments, so the incidence of these visits may have been overestimated. Third, telephone calls and secure messages may have been underestimated as only encounters with discrete entries in the EMR were counted. In addition, we were only able to count ER visits, hospitalizations, and clinic visits that took place at our study site. Patients may have presented to other health care system hospitals or walk-in clinics for care. Fourth, we may have underestimated some secure message and telephone utilization by excluding nonopioid prescription refills, which could have involved chronic pain adjuvants. Fifth, the opioid regimen was not available for all patients. A portion of patients who were no longer on a pain agreement or prescribed opioids at the end of the study period were not included in the analysis based on MED, number of opioids, and schedule. Along the same line, we did not account for opioid dose adjustments that may have happened throughout the study period. Also, residual confounding may persist despite model adjustment due to the difficulty in collecting information on all possible confounders, such as homelessness and socioeconomic status. Finally, given the retrospective nature of the study, determining causal effect was not possible.
Conclusion
Chronic pain is a significant medical condition associated with growing concerns of appropriate opioid use, general lack of effective treatment options, and increasing volume of affected patients. It is also associated with increased health care utilization. These aspects, in combination with the continued and mounting shortage of primary care providers, are setting a stage for a national crisis. Future studies are needed to examine whether more effective pain management improves health care utilization.
